Bayer AG’s stock slumped on Tuesday as the German giant issued a profit warning on agricultural demand. Germany-listed shares ...

At the time of writing, shares in Bayer were up 12.38% at €29.67, after the company won a legal battle to limit liability ...

New Prostate Cancer Hope? Bayer-Funded Phase 2 Study To Test Combination Of RedHill's Opaganib And Bayer's Darolutamide, To Overcome Androgen Resistance Regeneron's Best-Selling Eye Drug Eylea's ...

J.P. Morgan analyst Richard Vosser maintained a Hold rating on Bayer (0P6S – Research Report) today and set a price target of €25.00. The ...

Find the latest Bayer AG N BAYN.DE analyst stock forecast, price target, and recommendation trends with in-depth analysis from research reports.

Bayer Weedkiller Lawsuit Dismissed By Australian Judge: Insufficient Evidence Linking Roundup To Blood Cancer Australian judge dismisses class action lawsuit against Bayer for Roundup causing ...